149 filings
Page 7 of 8
8-K
o1dq5in5
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
8-K
qiegfnhsc 6n
9 Mar 20
Entry into a Material Definitive Agreement
5:06pm
8-K
7yrtbpxm3w0gd0
12 Feb 20
Vir Biotechnology Identifies Two Antibodies That Bind to The Spike Protein of
5:02pm
8-K
eukx97fl qsc1sacr4
30 Jan 20
Other Events
6:07am
8-K
ucudhk3zryz9ku eqd
23 Jan 20
Other Events
6:08am
10-Q
0c8w5to068qsdcuvklpb
19 Nov 19
Quarterly report
4:06pm
8-K
k18h3au94h zv550n3v1
19 Nov 19
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:05pm
8-K
o30r3p82stfxjmtbbe0h
16 Oct 19
Departure of Directors or Certain Officers
4:01pm
S-8
w3ie4aht30wwqvjdd0yk
15 Oct 19
Registration of securities for employees
4:47pm
424B4
k076qk5vdy58e
11 Oct 19
Prospectus supplement with pricing info
5:31pm
EFFECT
sq8i75vgj80e1adz1
11 Oct 19
Notice of effectiveness
12:15am
CERT
0fmose4mfc
10 Oct 19
Certification of approval for exchange listing
10:40am
8-A12B
px79xvo1 jp0
9 Oct 19
Registration of securities on exchange
2:09pm
CORRESP
86iyhrbq6akghkdp4t61
8 Oct 19
Correspondence with SEC
12:00am
CORRESP
5dsunmqs939l3bx1
8 Oct 19
Correspondence with SEC
12:00am
S-1/A
x1rmlmo
30 Sep 19
IPO registration (amended)
6:12am
CORRESP
bywfdoi
30 Sep 19
Correspondence with SEC
12:00am
SEC STAFF
vzhbxvm
20 Sep 19
SEC staff action: Order
12:00am
CORRESP
182y5q8 pc35
17 Sep 19
Correspondence with SEC
12:00am
UPLOAD
c40bcj2
10 Sep 19
Letter from SEC
12:00am